Cart
sales@molnova.com
PQ401 hydrochloride
CAS No. ——
PQ401 hydrochloride( —— )
Catalog No. M19402 CAS No. ——
PQ401 inhibits autophosphorylation of IGF-1R domain with IC50 of <1 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | Get Quote |
|
| 5MG | 74 | Get Quote |
|
| 10MG | 104 | Get Quote |
|
| 25MG | 184 | Get Quote |
|
| 50MG | 331 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePQ401 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionPQ401 inhibits autophosphorylation of IGF-1R domain with IC50 of <1 μM.
-
DescriptionPQ401 inhibits autophosphorylation of IGF-1R domain with IC50 of <1 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetIGF-1R
-
RecptorIGF-1R
-
Research AreaCancer
-
IndicationCancer
Chemical Information
-
CAS Number——
-
Formula Weight378.25
-
Molecular FormulaC18H17Cl2N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCl.COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gable KLetal Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol Cancer Ther. 2006 Apr;5(4):1079-86.
molnova catalog
related products
-
Linsitinib
Linsitinib (ASP-7487, OSI-906) is a potent, selective, orally active, dual IGF-1R/insulin receptor inhibitor with IC50 of 35/75 nM, respectively.
-
GIP (3-42), human
GIP (3-42), human (Gastric Inhibitory Polypeptide (3-42) (human)) is a peptide that acts as a glucose-dependent proinsulinotropic polypeptide (GIP) receptor antagonist and regulates insulin secretion and the metabolic effects of GIP in vivo, which can be used to study type 2 diabetes.
-
AZ7550 trimesylate s...
AZ7550 trimesylate salt (AZ7550 Mesylate) is the active metabolite of ositinib, AZ7550 trimesylate salt inhibits IGF1R activity and can be used in the study of non-small cell lung cancer.
